Promising Blood Biomarkers for Clinical Use in Alzheimer’s Disease: A Focused Update

Alzheimer’s disease (AD) is the most-common cause of neurodegenerative dementia, and it is characterized by abnormal amyloid and tau accumulation, which indicates neurodegeneration. AD has mostly been diagnosed clinically. However, ligand-specific positron emission tomography (PET) imaging, such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sun Ah, Jang, Yu Jung, Kim, Min Kyoung, Lee, Sun Min, Moon, So Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262460/
https://www.ncbi.nlm.nih.gov/pubmed/35796265
http://dx.doi.org/10.3988/jcn.2022.18.4.401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262460/
https://www.ncbi.nlm.nih.gov/pubmed/35796265
http://dx.doi.org/10.3988/jcn.2022.18.4.401

Ejemplares similares